Women may be at risk of weight gain during pregnancy, if they have polycystic ovarian syndrome, or during perimenopause or menopause
Science 303 , 495499 (2004)
Employers that are unwilling or unable to offer health plan coverage of GLP-1 drugs for weight management may consider offering consumer-driven health plans and tax-advantaged accounts, such as health savings accounts (HSAs) or flexible spending accounts (FSAs)
Eur J Clin Nutr 72:105111 Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA (2016) A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder
The cysteine proteome
Resveratrol and cardiovascular diseases